Intravenous itasetron: establishing the effective dose range for the prophylactic control of acute emesis in cancer patients undergoing high-dose cisplatin chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/10378635

Download in:

View as

General Info

PMID
10378635